Chemically synthesized Secoisolariciresinol diglucoside (LGM2605) improves mitochondrial function in cardiac myocytes and alleviates septic cardiomyopathy

  • Dimitra Kokkinaki
  • , Matthew Hoffman
  • , Charikleia Kalliora
  • , Ioannis D. Kyriazis
  • , Jennifer Maning
  • , Anna Maria Lucchese
  • , Santhanam Shanmughapriya
  • , Dhanendra Tomar
  • , Joon Young Park
  • , Hong Wang
  • , Xiao Feng Yang
  • , Muniswamy Madesh
  • , Anastasios Lymperopoulos
  • , Walter J. Koch
  • , Melpo Christofidou-Solomidou
  • , Konstantinos Drosatos

Research output: Contribution to journalArticlepeer-review

Abstract

Sepsis is the overwhelming systemic immune response to infection, which can result in multiple organ dysfunction and septic shock. Myocardial dysfunction during sepsis is associated with advanced disease and significantly increased in-hospital mortality. Our group has shown that energetic failure and excess reactive oxygen species (ROS) generation constitute major components of myocardial dysfunction in sepsis. Because ROS production is central to cellular metabolic health, we tested if the synthetic anti-oxidant lignan secoisolariciresinol diglucoside (SDG; LGM2605) would alleviate septic cardiac dysfunction and investigated the underlying mechanism. Using the cecal ligation and puncture (CLP) mouse model of peritonitis-induced sepsis, we observed impairment of cardiac function beginning at 4 h post-CLP surgery. Treatment of mice with LGM2605 (100 mg/kg body weight, i.p.) 6 h post-CLP surgery reduced cardiac ROS accumulation and restored cardiac function. Assessment of mitochondrial respiration (Seahorse XF) in primary cardiomyocytes obtained from adult C57BL/6 mice that had undergone CLP and treatment with LGM2605 showed restored basal and maximal respiration, as well as preserved oxygen consumption rate (OCR) associated with spare capacity. Further analyses aiming to identify the cellular mechanisms that may account for improved cardiac function showed that LGM2605 restored mitochondria abundance, increased mitochondrial calcium uptake and preserved mitochondrial membrane potential. In addition to protecting against cardiac dysfunction, daily treatment with LGM2605 and antibiotic ertapenem (70 mg/kg) protected against CLP-associated mortality and reversed hypothermia when compared against mice receiving ertapenem and saline. Therefore, treatment of septic mice with LGM2605 emerges as a novel pharmacological approach that reduces cardiac ROS accumulation, protects cardiac mitochondrial function, alleviates cardiac dysfunction, and improves survival.
Original languageEnglish
Pages (from-to)232-245
Number of pages14
JournalJournal of Molecular and Cellular Cardiology
Volume127
DOIs
StatePublished - Feb 2019

Bibliographical note

Copyright © 2019 Elsevier Ltd. All rights reserved.

Funding

This study was supported by the National Heart Lung and Blood Institute of the NIH “Pathway to Independence” K99/R00 award HL112853 (K.D.), HL130218 (K.D.), the W.W. Smith Charitable Trust (K.D), and P01HL091799 (W.J.K.). The work was also supported in part by 1P42ES023720-01 (M.C.S.). S.S. is supported by an NIH K99/R00 grant (1K99 HL138268-01). M.H. was supported by an American Heart Association pre-doctoral fellowship (18PRE34060115). I.D.K. was supported by the American Heart Association and the Kahn Family Post-Doctoral Fellowship in Cardiovascular Research (18POST34060150). D.T. was supported by American Heart Association post-doctoral fellowships (17POST33660251).

ASJC Scopus Subject Areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Keywords

  • Animals
  • Antioxidants/metabolism
  • Autophagy/drug effects
  • Biomarkers/metabolism
  • Butylene Glycols/chemical synthesis
  • Calcium/metabolism
  • Cardiomyopathies/complications
  • Cecum/pathology
  • Cell Line
  • Cytokines/blood
  • Disease Models, Animal
  • Gene Expression Regulation/drug effects
  • Glucosides/chemical synthesis
  • Humans
  • Inflammation Mediators/metabolism
  • Ligation
  • Membrane Potential, Mitochondrial/drug effects
  • Mice, Inbred C57BL
  • Mitochondria, Heart/drug effects
  • Myocardium/metabolism
  • Myocytes, Cardiac/drug effects
  • NF-kappa B/metabolism
  • Organelle Biogenesis
  • Oxidative Stress/drug effects
  • Oxygen Consumption/drug effects
  • Punctures
  • Sepsis/complications

Disciplines

  • Molecular Biology
  • Cardiology

Fingerprint

Dive into the research topics of 'Chemically synthesized Secoisolariciresinol diglucoside (LGM2605) improves mitochondrial function in cardiac myocytes and alleviates septic cardiomyopathy'. Together they form a unique fingerprint.

Cite this